Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.4786
-0.0343 (-6.69%)
Mar 31, 2025, 2:30 PM EDT - Market open
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $41.18 million as of March 31, 2025. Its market cap has decreased by -85.84% in one year.
Market Cap
41.18M
Enterprise Value
-91.33M
1-Year Change
-85.84%
Ranking
Category
Stock Price
$0.48
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $41.18M, a decrease of -96.08%. That is a compound annual growth rate of -57.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 44.13M | -48.61% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.37B |
| UnitedHealth Group | 481.12B |
| Johnson & Johnson | 400.55B |
| AbbVie | 372.38B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.26B |
| AstraZeneca | 229.16B |
| Merck & Co. | 225.18B |